Jazz Pharmaceuticals plc — Director's Dealing 2015

Aug 11, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-08-11

Reporting Person: Treacy Paul (SVP, Technical Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-11	Ordinary Shares	S	1309	$177.82	Disposed	11422	Direct
2015-08-11	Ordinary Shares	S	21	$177.5125	Disposed	11401	Direct

Footnotes

F1: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

F2: Includes 46 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 29, 2015.